Back to Agenda
Shortages of Authorised Products
Session Chair(s)
Brendan Cuddy, MSc
Lead Scientific Officer
European Medicines Agency, Netherlands
The shortages of medicines have been increasing in recent years. Do we have solutions for this global and multidimensional problem?
Learning Objective : You will be able to understand that medicine shortages are due to very diverse causes (including manufacturing, business and economic causes) and that a solution to such shortages will require a holistic approach that takes into consideration these different factors.
Speaker(s)
Medicinal Product Shortages
Brendan Cuddy, MSc
European Medicines Agency, Netherlands
Lead Scientific Officer
Supply Continuity – Regulatory Interventions
Gerald W. Heddell
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Director, Inspection Enforcement & Standards Division
Medicines Shortages – Towards an Integrated Approach to Tackling Medicines Shortages on the European Market
Koen Nauwelaerts, PharmD, PhD, MBA
Bayer AG, Belgium
Regulatory Policy and Innovation Lead
Have an account?